Therapy of Type-2-Diabetes

被引：0

作者：

Landgraf, Ruediger ^{[1
]}

Aberle, Jens ^{[2
]}

Birkenfeld, Andreas L. ^{[3
,4
]}

Gallwitz, Baptist ^{[4
]}

Kellerer, Monika ^{[5
]}

Klein, Harald ^{[6
]}

Mueller-Wieland, Dirk ^{[7
]}

Nauck, Michael A. ^{[8
]}

Reuter, Hans-Martin ^{[9
]}

Siegel, Erhard ^{[10
]}

机构：

[1] Deutsch Diabet Stiftung, Dusseldorf, Germany

[2] Univ Klinikum Hamburg Eppendorf, Univ Adipositas Zentrum Hamburg, Sekt Endokrinol & Diabetol, Hamburg, Germany

[3] Deutsch Zentrum Diabet Forsch DZD eV, Neuherberg, Germany

[4] Univ Klinikum Tubingen, Med Klin 4, Diabetol, Nephrol,Endokrinol, Tubingen, Germany

[5] Zentrum Innere Med 1, Marienhosp Stuttgart, Stuttgart, Germany

[6] Berufsgenossenschaftliches Univ Klinikum Bergmann, Med Klin 1, Bochum, Germany

[7] Univ Klinikum RWTH Aachen, Med Klin 1, Aachen, Germany

[8] Ruhr Univ, Diabet Zentrum Bochum Hattingen, St Josef Hosp, Bochum, Germany

[9] Diabetol Schwerpunktpraxis, Jena, Germany

[10] St Josefkrankenhaus Heidelberg GmbH, Abt Innere Med Gastroenterol Diabetol Endokrinol, Heidelberg, Germany

来源：

DIABETOLOGE | 2021年 / 17卷 / 04期

关键词：

TYPE-2; DIABETES-MELLITUS; PEPTIDE-1 RECEPTOR AGONISTS; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; ALL-CAUSE MORTALITY; ESTABLISHED CARDIOVASCULAR-DISEASE; LY2963016 INSULIN GLARGINE; COTRANSPORTER; INHIBITORS; JOINT WORKING GROUP; BASAL INSULIN; ACUTE-PANCREATITIS;

D O I：

10.1007/s11428-021-00765-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：422 / 447

页数：26

共 50 条

[31] Effectiveness of the incretin therapy in type-2-Diabetes - A meta-analysis
Rose, B.
DIABETOLOGE, 2008, 4 (02): : 125 - 126
[32] Glycemic Control in Patients with Type-2-Diabetes in geriatric Facilities depending on the Diabetes Therapy
Libiseller, Angela
Lichtenegger, Katharina Maria
de Campo, Antonella
Wiesinger, Tatjana
Stolletz, Nicole
Cuder, Gerald
Hoell, Bernhard
Schaupp, Lukas
Beck, Peter
Plank, Johannes
Pieber, Thomas R.
WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : 179 - 180
[33] Oral Combination Therapy for the Treatment of Type-2-Diabetes Glucose Control with Dapagliflozin
Schmidt, Lena
DIABETES STOFFWECHSEL UND HERZ, 2014, 23 (04): : 221 - 222
[34] Type-2-Diabetes: Bariatric Surgery more effective than Drug Therapy
Lichert, Frank
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (08) : 566 - U29
[35] The case history: Combination therapy of the Type-2-Diabetes mellitus with Insulin and Pioglitazone
Lundershausen, Rainer
DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (03) : 146 - 147
[36] Hypoglycemia - a major Barrier in the Insulin Therapy for the Type-2-Diabetes and Solution Approaches
Prager, R.
AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2015, 8 (04): : 120 - 122
[37] SGLT2-Inhibitors vs. Sulfonylureas in the Therapy of Type-2-Diabetes
Gappa, Birgit
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (22) : 1443 - 1444
[38] Insulin in Type-2-Diabetes and old Age
不详
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (09) : 587 - 587
[39] Case Report: Type-2-Diabetes and Depression
Hofmann, P.
AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2016, 9 (02): : 50 - 50
[40] Cancers increase the Risk of Type-2-Diabetes
Lichert, Frank
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (11): : 1330 - +

← 1 2 3 4 5 →